![Alessandro Riva](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alessandro Riva
Vorstandsvorsitzender bei
TRANSGENE
Vermögen: 4 Mio $ am 31.05.2026
Profil
Alessandro Riva was the founder of Intima Bioscience, Inc., founded in 2021, where the title held was Chief Executive Officer from 2021 to 2023.
Dr. Riva is also the founder of Breast Cancer International Research Group Ltd.,Cancer International Research Group..
Dr. Riva is Chairman & Chief Executive Officer at Transgene SA since 2023, Independent Director at Century Therapeutics, Inc. since 2021, Independent Non-Executive Director at BeOne Medicines Ltd. since 2022, and Independent Director at Bicycle Therapeutics Plc starting in 2025.
Former positions include Chief Executive Officer-Innovation Business at Glenmark Pharmaceuticals Ltd., Director at Ichnos Glenmark Innovation, Inc. in 2021, Director at Century Therapeutics, Inc. in 2021, Executive VP-Oncology Therapeutics at Gilead Sciences, Inc. from 2017 to 2019, President at Novartis Oncology, Inc. from 2005 to 2016, VP, Head-Oncology Development & Medical Affairs at Novartis AG from 2005 to 2016, and EVP, Head-Oncology Development & Medical Affairs at Novartis Pharmaceuticals Corp.
Education includes undergraduate and doctorate degrees from the University of Milan.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BEONE MEDICINES LTD. 0,01 % | 22.05.2026 | 192.530 ( 0,01 % ) | 4 Mio $ | 31.05.2026 |
TRANSGENE SA 0,03 % | 31.12.2024 | 93.075 ( 0,03 % ) | 90 692 $ | 31.05.2026 |
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Alessandro Riva
| Unternehmen | Position | Beginn |
|---|---|---|
| BEIGENE LTD | Direktor/Vorstandsmitglied | 01.02.2022 |
| CENTURY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2021 |
| TRANSGENE | Vorstandsvorsitzender | 01.06.2023 |
| BICYCLE THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 25.03.2025 |
Ehemalige bekannte Positionen von Alessandro Riva
| Unternehmen | Position | Ende |
|---|---|---|
Intima Bioscience, Inc.
 Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products to treat cancer | Vorstandsvorsitzender | 01.04.2023 |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Vorstandsvorsitzender | 21.05.2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 06.03.2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01.12.2016 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Präsident | 01.01.2016 |
Ausbildung von Alessandro Riva
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Glenmark Pharmaceuticals Ltd.
 Glenmark Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of Milan
 University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Breast Cancer International Research Group Ltd.
 Breast Cancer International Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Breast Cancer International Research Group Ltd. is an organization focused on breast cancer research. The private company is based in Edmonton, Canada. The Canadian company was founded by Alessandro Riva. | Commercial Services |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products to treat cancer | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cancer International Research Group |
